Capital Allocation and Financial Overview

8% 6% 4% 0% ៖ ៖ ៖ ៖ ៖ ៖ 44% 40% 36% 32% 28% 24% 20% 2001 Continuous Improvement(a) Gross Margin (b) 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 10% R&D Expense (c) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 9Mo. '20 2019 9Mo. '20 45% 40% 35% 30% 25% 20% 15% 10% 4% EBITDA Margin 20% 18% 16% 14% 12% 10% 8% 6% 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 9Mo. '20 50% International Sales (%) (a) 2009-2012 represent data from continuing operations. See page 23 for a reconciliation of GAAP to non-GAAP amounts (b) Represents gross margin as filed in historical SEC filings, which do not reflect ASU No. 2017-07: Improving the Presentation of Net Periodic Pension Cost, etc. for 2016 and prior years (c) Represents company-funded research and development expense, including bid and proposal expense, as a percentage of sales 7 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 9Mo. '20

View entire presentation